Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Mogrify Ltd.
Headquarters: Cambridge, United Kingdom
Website: http://www.mogrify.co.uk
Year Founded: 2016
Status: Private
BioCentury | Jul 16, 2024
Management Tracks
More moves at the top for I-Mab
Plus: Daniel Janse named CEO at AffyImmune, and updates from HanAll, Mogrify, Rectify and Atsena
BioCentury | Jun 15, 2023
Product Development
iPSC programs extend well beyond NK cell therapies
Biotechs are developing over 20 types of iPSC-based cell therapies
BioCentury | May 3, 2023
Management Tracks
Filius to depart Galapagos
Plus: Modis joins Amphista as CSO and updates from ObsEva, CS Genetics, Resolution and Newron
BioCentury | Jul 6, 2022
Deals
July 5 Quick Takes: Details of Pfizer-Biohaven negotiations emerge
Plus second adcomm for Amylyx’s ALS therapy, female biotech leaders criticize SCOTUS decision, and updates from Juvisé, Syros and more
BioCentury | Feb 9, 2022
Product Development
Tregs and gene regulation define Sangamo’s next act
Sangamo takes a second shot at a first mover advantage as it pivots from gene editing to engineering Treg cell therapies
BioCentury | Oct 5, 2021
Management Tracks
Medicxi’s Grainger joins Centessa as chief innovation officer
Plus: Certara, MOMA, Quotient, Mogrify, Acadia, CorMedix and more
BioCentury | Apr 23, 2020
Product Development
April 22 Quick Takes: Accelerated approval for Immunomedics’ Trodelvy; plus BioNTech-Pfizer, AskBio, Astellas, Merck KGaA, oNKo-Gilead, Myovant, Afyx and Sangam
BioCentury | Oct 14, 2019
Financial News
Mogrify raises $16M, outlines plans to advance cell therapy platform
BioCentury | Sep 9, 2019
Company News
Management tracks: Coles to lead Cerevel; plus Genfit, Jubilant, Paratek, Mogrify, Dementia Discovery Fund and Ayala
BioCentury | May 22, 2019
Company News
Management tracks: Gottlieb re-joining NEA; plus Seattle Genetics, Celsius and more
Items per page:
1 - 10 of 12